Par Pharmaceutical

PAR PHARMACEUTICAL NAMES PAUL CAMPANELLI PRESIDENT, GENERICS DIVISION

Published in Pharma Law Weekly, March 27th, 2007

Par Pharmaceutical Companies, Inc. (NYSE:PRX) today announced that Paul V. Campanelli has been named president, Generics Division. In this capacity, Mr. Campanelli will head the fifth largest U.S. generic pharmaceutical company and continue to oversee the Business Development and Licensing group he formed when he joined Par in 2001. He has also been elected a corporate officer by the company's board of directors.

"We are fortunate to have a leader like Paul, whose energy, industry knowledge and management expertise I'm confident will continue to help grow this important business," said Patrick G. LePore, president and chief executive officer. "The quality of Par's...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Law Weekly

Source: Pharma Law Weekly (2007-03-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry

Search our medical news database